Rydex Investments

BioSynexus, located in Gaithersburg, MD, is dedicated to transforming the prevention and treatment of bacterial infections, with a particular emphasis on staphylococcal infections in very low birth weight infants. The company focuses on developing innovative, antibody-based, and enzymatic therapies to protect the most vulnerable populations in neonatal intensive care units (NICUs). With a mission to combat antibiotic-resistant infections, BioSynexus is advancing solutions such as Pagibaximab, Lysostaphin, and Nisin, each targeting resistant strains of Staphylococcus aureus effectively and safely. Their efforts are aimed at reducing neonatal mortality and healthcare costs associated with recurrent infections while supporting global initiatives against antimicrobial resistance. Generated from the website

Westat is a research services company based in Gaithersburg, MD, dedicated to improving lives through innovative solutions in health, education, social policy, and transportation. By integrating transformative technology with interdisciplinary expertise, Westat provides comprehensive clinical research and biostatistics services to federal and commercial clients, ensuring high-quality outcomes and insights. With a focus on addressing critical issues such as food insecurity and public health, Westat employs advanced methodologies in survey design and data collection to deliver effective solutions. Their commitment to social responsibility and collaboration positions them as a leader in the research community, tackling emerging questions and enhancing the nation's health. Generated from the website